Winton Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,027
| Closed | -$285K | – | 778 |
|
|
2024
Q2 | $285K | Sell |
36,027
-38,484
| -52% | -$304K | 0.02% | 495 |
|
|
2024
Q1 | $694K | Buy |
74,511
+28,979
| +64% | +$270K | 0.05% | 419 |
|
|
2023
Q4 | $384K | Sell |
45,532
-4,094
| -8% | -$34.6K | 0.03% | 448 |
|
|
2023
Q3 | $385K | Buy |
49,626
+25,284
| +104% | +$196K | 0.03% | 396 |
|
|
2023
Q2 | $279K | Buy |
+24,342
| New | +$279K | 0.02% | 549 |
|
|
2021
Q4 | – | Sell |
-24,287
| Closed | -$64K | – | 1425 |
|
|
2021
Q3 | $64K | Buy |
24,287
+6,060
| +33% | +$16K | ﹤0.01% | 1302 |
|
|
2021
Q2 | $75K | Buy |
+18,227
| New | +$75K | ﹤0.01% | 1394 |
|
|
2020
Q1 | – | Sell |
-36,390
| Closed | -$508K | – | 1556 |
|
|
2019
Q4 | $508K | Buy |
+36,390
| New | +$508K | 0.01% | 1236 |
|